CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,477 | $566.19 | $836K | 48,536 |
| 2026-05-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,874 | $567.04 | $1.1M | 46,662 |
| 2026-05-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,211 | $568.07 | $1.8M | 43,451 |
| 2026-05-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,682 | $569.03 | $957K | 41,769 |
| 2026-05-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −616 | $569.94 | $351K | 41,153 |
| 2026-05-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $571.23 | $183K | 40,833 |
| 2026-05-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $572.25 | $183K | 40,513 |
| 2026-05-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 221,410 | ||
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −80 | $568.74 | $45K | 28,796 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −80 | $570.52 | $46K | 28,716 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −603 | $571.53 | $345K | 28,113 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −970 | $572.78 | $556K | 27,143 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,456 | $574.04 | $1.4M | 24,687 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,419 | $574.76 | $2.0M | 21,268 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,712 | $575.78 | $986K | 19,556 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −293 | $576.75 | $169K | 19,263 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −307 | $577.93 | $177K | 18,956 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −80 | $578.59 | $46K | 18,876 |
| 2026-05-14 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 2,500 |
Page 102 of 121 · 2,404 trades